Bristol-Myers Squibb Financials

Bristol-Myers Squibb Co

BMYNYSE

Trade with Public

$63.06

0.220.35%

al cierre: Sep 18, 5:00 PM EST

$63.02

-0.0435-0.07%

After hour: Sep 18, 7:54 PM EST

Dividendo: La fecha límite del dividendo es dentro de 12 días

Panorámica general Noticias Previsión de beneficios Eventos Precios objetivoFinanzasSentimiento Propiedad Dividendos Comparar Informe de acciones

Bristol-Myers Squibb Financials

Bristol-Myers Squibb (BMY) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Oil Sinks 6%, Nasdaq 100 Rallies On Iran Talks: Stock Market Today

Crude tumbles nearly 6% after Trump cancels a strike on Iran, lifting the S&P 500 1.3% and the Russell 2000 1.5% at midday Monday.

Piero Cingari

Bristol-Myers Boosts 2026 Guidance on Portfolio Strength

Bristol-Myers beats Q2 earnings and revenue estimates, driven by growth drugs, while raising its full-year 2026 sales and profit outlook.

Vandana Singh

PRO
Bristol-Myers Squibb Raises FY2026 Adj EPS Guidance from $6.05-$6.35 to $6.75-$7.00 vs $6.34 Est; Raises FY2026 Sales Guidance from $46.000B-$47.500B to $49.000B-$50.000B vs $47.472B Est

Bristol-Myers Squibb (NYSE:BMY) raises FY2026 Adj EPS guidance from $6.05-$6.35 to $6.75-$7.00 vs $6.34 analyst estimate. Raises FY2026 sales outlook from $46.000 billion-$47.500 billion to $49.000 billion-$50.000

Benzinga Newsdesk

PRO
Bristol-Myers Squibb Q2 Adj. EPS $2.04 Beats $1.59 Estimate, Sales $12.973B Beat $11.745B Estimate

Benzinga Newsdesk

Dow Records Worst Session Since April 2025; Investor Sentiment Weakens, Greed Index Remains In ‘Fear’ Zone

The CNN Money Fear and Greed index showed a sharp decline in market sentiment as stocks fell and oil prices rose due to US-Iran tensions.

Avi Kapoor

Apple, Microsoft And 3 Stocks To Watch Heading Into Thursday

U.S. stock futures trading higher, focus on Apple, Microsoft, Amazon earnings. Meta posts mixed results, Bristol-Myers Squibb to release earnings.

Avi Kapoor

Bristol-Myers Squibb Co

Bristol-Myers Squibb Financials

Earnings & Guidance News

Oil Sinks 6%, Nasdaq 100 Rallies On Iran Talks: Stock Market Today

Bristol-Myers Boosts 2026 Guidance on Portfolio Strength

PRO
Bristol-Myers Squibb Raises FY2026 Adj EPS Guidance from $6.05-$6.35 to $6.75-$7.00 vs $6.34 Est; Raises FY2026 Sales Guidance from $46.000B-$47.500B to $49.000B-$50.000B vs $47.472B Est

PRO
Bristol-Myers Squibb Q2 Adj. EPS $2.04 Beats $1.59 Estimate, Sales $12.973B Beat $11.745B Estimate

Dow Records Worst Session Since April 2025; Investor Sentiment Weakens, Greed Index Remains In ‘Fear’ Zone

Apple, Microsoft And 3 Stocks To Watch Heading Into Thursday

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Bristol-Myers Squibb Co

Bristol-Myers Squibb Financials

Earnings & Guidance News

Oil Sinks 6%, Nasdaq 100 Rallies On Iran Talks: Stock Market Today

Bristol-Myers Boosts 2026 Guidance on Portfolio Strength

PROBristol-Myers Squibb Raises FY2026 Adj EPS Guidance from $6.05-$6.35 to $6.75-$7.00 vs $6.34 Est; Raises FY2026 Sales Guidance from $46.000B-$47.500B to $49.000B-$50.000B vs $47.472B Est

PROBristol-Myers Squibb Q2 Adj. EPS $2.04 Beats $1.59 Estimate, Sales $12.973B Beat $11.745B Estimate

Dow Records Worst Session Since April 2025; Investor Sentiment Weakens, Greed Index Remains In ‘Fear’ Zone

Apple, Microsoft And 3 Stocks To Watch Heading Into Thursday

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

PRO
Bristol-Myers Squibb Raises FY2026 Adj EPS Guidance from $6.05-$6.35 to $6.75-$7.00 vs $6.34 Est; Raises FY2026 Sales Guidance from $46.000B-$47.500B to $49.000B-$50.000B vs $47.472B Est

PRO
Bristol-Myers Squibb Q2 Adj. EPS $2.04 Beats $1.59 Estimate, Sales $12.973B Beat $11.745B Estimate